![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Friday, September 16, 2011 4:42:40 PM
Marc told me earlier this week that it takes a prescription in Europe just to buy Vitamin C!!
OUCH!
And I thought we had issues with the US FDA!
I got to thinking after Gold's recent bearish comments on IFUS about some good comparisons. I may work on a post for that this weekend. The theme being, to compare say CYTR to IFUS.
CYTR has no sales, a huge known cost going forward with its new drug trials, yet the market cap has been in the $100 million dollar area for years, as they burn through 5 to 20 million dollars or more per year,
and yet at today's price IFUS is sporting a tiny market cap of only about $350,000, for a company with a product that works, and that has real revenue, and product sales, that are climbing.
There are many good CYTR comparisons. Point being that I see IFUS as undervalued!
Ambition with out knowledge is like ship in dry dock. Going nowhere fast!
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM